Toral Patel, MD
Dermatology · Lombard, ILNPI 1346409919
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,680 of the $5,935 with a category attached, or 62.0%. Viiv Healthcare Company accounts for 68.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $4,050 and has fallen 91.8% since, to $331 in 2025.
Across 38 payments — averaging $156.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$4K
- Melinta Therapeutics, LLC$1K
- Galderma Laboratories, L.p.$188
- Gilead$150
- Johnson & Johnson$95
- Shionogi Inc$78
- plus $100 from 3 others
What the payments were for
- Consulting fees$3,68062%
- Speaking & faculty fees$1,13819%
- Travel & lodging$170%
- Food & beverage$97516%
- Education$1262%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 13 | $4,056 |
| Melinta Therapeutics, LLC | 7 | $1,267 |
| Galderma Laboratories, L.p. | 3 | $188 |
| Gilead | 5 | $150 |
| Johnson & Johnson | 1 | $95 |
| Shionogi Inc | 4 | $78 |
| Incyte Corporation | 2 | $45 |
| Pfizer | 2 | $31 |
| Lilly USA, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,935 in reported general payments places this provider in the 70th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 29 | $369 |
| Minoxidil | 24 | $342 |
| Desonide | 12 | $296 |
| Triamcinolone Acetonide | 18 | $104 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lombard
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
- Emily RubensteinLincolnshire$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.